Haleon plc (HLN) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Haleon plc (HLN) has a cash flow conversion efficiency ratio of 0.055x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($902.61 Million) by net assets ($16.34 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Haleon plc for the company's overall valuation and market capitalisation.
Haleon plc - Cash Flow Conversion Efficiency Trend (2019–2025)
This chart illustrates how Haleon plc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Haleon plc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Haleon plc ranked by their cash flow conversion efficiency. Explore earnings quality score of Haleon plc to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Paychex Inc
NASDAQ:PAYX
|
0.156x |
|
Orange S.A.
PA:ORA
|
0.179x |
|
LONZA GROUP UNSP.ADR 1/10
F:LO3A
|
N/A |
|
Microchip Technology Inc
NASDAQ:MCHP
|
0.040x |
|
ASSA ABLOY AB (publ)
ST:ASSA-B
|
0.073x |
|
Block, Inc
NYSE:XYZ
|
0.045x |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
0.215x |
|
Ferrovial SE
NASDAQ:FER
|
0.106x |
Annual Cash Flow Conversion Efficiency for Haleon plc (2019–2025)
The table below shows the annual cash flow conversion efficiency of Haleon plc from 2019 to 2025. View latest Haleon plc stock price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $16.46 Billion | $2.29 Billion | 0.139x | -2.06% |
| 2024-12-31 | $16.22 Billion | $2.30 Billion | 0.142x | +12.98% |
| 2023-12-31 | $16.73 Billion | $2.10 Billion | 0.126x | +0.14% |
| 2022-12-31 | $16.46 Billion | $2.06 Billion | 0.125x | +144.80% |
| 2021-12-31 | $26.48 Billion | $1.36 Billion | 0.051x | -4.56% |
| 2020-12-31 | $26.22 Billion | $1.41 Billion | 0.054x | +87.12% |
| 2019-12-31 | $27.41 Billion | $786.00 Million | 0.029x | -- |
About Haleon plc
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, and Biotene brands; an… Read more